{"id":"https://openalex.org/W4297982041","doi":"https://doi.org/10.1016/j.annonc.2022.08.077","title":"LBA71 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 743","display_name":"LBA71 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 743","publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4297982041","doi":"https://doi.org/10.1016/j.annonc.2022.08.077"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2022.08.077","doi":"https://doi.org/10.1016/j.annonc.2022.08.077","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.08.077","pdf_url":"http://www.annalsofoncology.org/article/S0923753422039552/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753422039552/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063103135","display_name":"G\u00e9rard Zalcman","orcid":"https://orcid.org/0000-0002-0343-9575","observed_orcids":["https://orcid.org/0000-0002-0343-9575","https://orcid.org/0000-0002-6013-599X"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Zalcman","raw_affiliation_strings":["Thoracic Oncology, Bichat-Claude Bernard University Hospital, AP-HP, Universit\u00e9 de Paris, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Bichat-Claude Bernard University Hospital, AP-HP, Universit\u00e9 de Paris, Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051846247","display_name":"Youssef Oulkhouir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114068","display_name":"Centre Hospitalier Universitaire de Caen Normandie","ror":"https://ror.org/027arzy69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210114068"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Y. Oulkhouir","raw_affiliation_strings":["Pulmonary and Thoracic Oncology, H\u00f4pital C\u00f4te de Nacre CHU Caen, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Thoracic Oncology, H\u00f4pital C\u00f4te de Nacre CHU Caen, Caen, France","institution_ids":["https://openalex.org/I4210114068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051331698","display_name":"Robin Cornelissen","orcid":"https://orcid.org/0000-0002-4289-3092","observed_orcids":["https://orcid.org/0000-0002-4289-3092"]},"institutions":[{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R. Cornelissen","raw_affiliation_strings":["Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064215820","display_name":"Laurent Greillier","orcid":"https://orcid.org/0000-0002-5807-9503","observed_orcids":["https://orcid.org/0000-0002-5807-9503"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210115034","display_name":"H\u00f4pital Nord","ror":"https://ror.org/029a4pp87","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210115034"]},{"id":"https://openalex.org/I4210144608","display_name":"Centre de Recherche en Canc\u00e9rologie de Marseille","ror":"https://ror.org/0494jpz02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210096427","https://openalex.org/I4210144608","https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Greillier","raw_affiliation_strings":["Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University, APHM, INSERM, CNRS, CRCM, H\u00f4pital Nord, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University, APHM, INSERM, CNRS, CRCM, H\u00f4pital Nord, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210115034","https://openalex.org/I4210144608"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112243044","display_name":"Jer\u00f3nimo Rodr\u00edguez Cid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102695","display_name":"Instituto Nacional de Enfermedades Respiratorias","ror":"https://ror.org/017fh2655","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210102695"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"J.R. Rodriguez Cid","raw_affiliation_strings":["Medical Oncology, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210102695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055246540","display_name":"Julien Mazi\u00e8res","orcid":"https://orcid.org/0000-0002-5921-7613","observed_orcids":["https://orcid.org/0000-0002-5921-7613"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210127828","display_name":"H\u00f4pital Larrey","ror":"https://ror.org/03471w967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210127828"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Mazieres","raw_affiliation_strings":["Pneumonology, Service de Pneumologie, Centre Hospitalier Universitaire de Toulouse - H\u00f4pital Larrey, Universit\u00e9 Paul Sabatier, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pneumonology, Service de Pneumologie, Centre Hospitalier Universitaire de Toulouse - H\u00f4pital Larrey, Universit\u00e9 Paul Sabatier, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I3019448017","https://openalex.org/I4210127828"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Briggs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801350665","display_name":"Monash Medical Centre","ror":"https://ror.org/036s9kg65","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801350665","https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"P. Briggs","raw_affiliation_strings":["Oncology Department, Monash Medical Centre, Clayton, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Monash Medical Centre, Clayton, VIC, Australia","institution_ids":["https://openalex.org/I2801350665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015006267","display_name":"Anna K. Nowak","orcid":"https://orcid.org/0000-0002-9317-9526","observed_orcids":["https://orcid.org/0000-0002-9317-9526"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802220196","display_name":"Sir Charles Gairdner Hospital","ror":"https://ror.org/01hhqsm59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802220196","https://openalex.org/I4210133657","https://openalex.org/I4396570646"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"A.K. Nowak","raw_affiliation_strings":["Medical School, University of Western Australia and Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School, University of Western Australia and Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802220196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057281549","display_name":"Anne S. Tsao","orcid":"https://orcid.org/0000-0003-0505-6639","observed_orcids":["https://orcid.org/0000-0003-0505-6639"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Tsao","raw_affiliation_strings":["Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003419889","display_name":"N. Fujimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145491","display_name":"Okayama Rosai Hospital","ror":"https://ror.org/04cmadr83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145491"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N. Fujimoto","raw_affiliation_strings":["Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan","institution_ids":["https://openalex.org/I4210145491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063300526","display_name":"Solange Peters","orcid":"https://orcid.org/0000-0002-0412-7143","observed_orcids":["https://orcid.org/0000-0002-0412-7143"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Peters","raw_affiliation_strings":["Oncology Department, Lausanne University Hospital, Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Lausanne University Hospital, Lausanne, Switzerland","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071440718","display_name":"Aaron Scott Mansfield","orcid":"https://orcid.org/0000-0002-9483-6903","observed_orcids":["https://orcid.org/0000-0002-9483-6903"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.S. Mansfield","raw_affiliation_strings":["Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048231332","display_name":"Sanjay Popat","orcid":"https://orcid.org/0000-0003-2087-4963","observed_orcids":["https://orcid.org/0000-0003-2087-4963"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Popat","raw_affiliation_strings":["Lung Unit, Royal Marsden Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung Unit, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073084463","display_name":"A. Nassar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Nassar","raw_affiliation_strings":["Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000745839","display_name":"Judith Bushong","orcid":"https://orcid.org/0009-0003-8203-5759","observed_orcids":["https://orcid.org/0009-0003-8203-5759"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Bushong","raw_affiliation_strings":["Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101666510","display_name":"Nan Hu","orcid":"https://orcid.org/0000-0002-0304-766X","observed_orcids":["https://orcid.org/0000-0002-0304-766X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Hu","raw_affiliation_strings":["Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047990253","display_name":"Thomas E. Spires","orcid":"https://orcid.org/0009-0006-7217-6269","observed_orcids":["https://orcid.org/0009-0006-7217-6269"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Spires","raw_affiliation_strings":["Translational Medicine, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062847058","display_name":"David Balli","orcid":"https://orcid.org/0000-0002-3007-4495","observed_orcids":["https://orcid.org/0000-0002-3007-4495"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Balli","raw_affiliation_strings":["Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002461369","display_name":"Laura J. Eccles","orcid":"https://orcid.org/0009-0002-9543-1745","observed_orcids":["https://orcid.org/0009-0002-9543-1745"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Eccles","raw_affiliation_strings":["Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":null,"display_name":"P. Baas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P. Baas","raw_affiliation_strings":["Department of Thoracic Oncology, Netherlands Cancer Institute and Leiden University Medical Center, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Netherlands Cancer Institute and Leiden University Medical Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2800006345","https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":25,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4230,"currency":"USD","value_usd":4230},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":null,"first_page":"S1438","last_page":"S1439"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/malignant-pleural-mesothelioma","display_name":"malignant pleural mesothelioma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/unresectable-mesothelioma","display_name":"unresectable mesothelioma","score":0.847000002861023},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6990000009536743},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9610000252723694},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6840000152587891},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7429999709129333},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8987044095993042},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7959414124488831},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6746399998664856},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.6694123148918152},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5293722152709961},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4603523910045624},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.43910086154937744},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.4332195818424225},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31475359201431274},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3047173321247101},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.28128260374069214},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20094725489616394},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.14299824833869934},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.annonc.2022.08.077","doi":"https://doi.org/10.1016/j.annonc.2022.08.077","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.08.077","pdf_url":"http://www.annalsofoncology.org/article/S0923753422039552/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pure.atira.dk:publications/73a0b84c-0953-49c9-b92f-76a6ffa2c296","doi":null,"is_oa":false,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/73a0b84c-0953-49c9-b92f-76a6ffa2c296","pdf_url":null,"source":{"id":"https://openalex.org/S4306402523","display_name":"UWA Profiles and Research Repository (University of Western Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2022.08.077","doi":"https://doi.org/10.1016/j.annonc.2022.08.077","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.08.077","pdf_url":"http://www.annalsofoncology.org/article/S0923753422039552/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320327811","display_name":"PharmaMar","ror":"https://ror.org/02h694m69"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4297982041.pdf","grobid_xml":"https://content.openalex.org/works/W4297982041.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3203219279","https://openalex.org/W3111212474","https://openalex.org/W4316040638","https://openalex.org/W4388197177","https://openalex.org/W7131216611","https://openalex.org/W4210792133","https://openalex.org/W2765874934","https://openalex.org/W3122627530","https://openalex.org/W7131782268","https://openalex.org/W7131797084"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2022-10-01T00:00:00"}